Shamburg News · 8-K filed Oct 9, 2026, 5:19 PM EDT
Serina Therapeutics Eliminates Series A Convertible Preferred Stock Designation from Charter
SER · Serina Therapeutics, Inc.
- Other
- Materiality: low
On October 5, 2026, Serina Therapeutics, Inc. filed a Certificate of Elimination with the Delaware Secretary of State removing the Series A Convertible Preferred Stock designations from its certificate of incorporation. The filing states that no Series A Preferred Stock is outstanding because all shares were converted into common stock, and the eliminated shares became authorized but unissued preferred stock without series designation.
Source: SEC EDGAR, Form 8-K, Items 5.03, 9.01, accession 0001708599-26-000060.
Written from the filing by Shamburg Markets. Figures are as reported by the company.